Antibiotic use in sexually transmissible diseases
Ted Rosen1, Travis Vandergriff, Mandy Harting
1Department of Dermatology, Baylor College of Medicine, 1 Baylor Plaza, Houston, TX 77030, USA. vampireted@aol.com
Dermatologic Clinics
|November 6, 2008
Summary
Antibiotic resistance is changing how we treat bacterial sexually transmitted diseases (STDs). Current guidelines recommend specific antibiotics for syphilis, chancroid, lymphogranuloma venereum, donovanosis, and gonorrhea, with adjustments for evolving microbial susceptibility.
Area of Science:
- Infectious Diseases
- Microbiology
- Public Health
Background:
- Sexually transmitted diseases (STDs) represent a significant global health burden, with hundreds of millions of new cases each year.
- Bacterial STDs are treatable with antibiotics, but changing microbial susceptibility patterns necessitate updated treatment strategies.
- Emerging resistance and treatment failures underscore the need for evidence-based therapeutic recommendations.
Purpose of the Study:
- To review current antibiotic treatment guidelines for common bacterial sexually transmitted infections.
- To highlight effective single-dose and prolonged antibiotic regimens for specific STDs.
- To address the management of reemergent infections and complex cases like genital bite wounds.
Main Methods:
- Review of current literature and clinical guidelines for the management of bacterial STDs.
- Analysis of antibiotic susceptibility patterns and their impact on treatment efficacy.
- Synthesis of recommended therapeutic approaches for various etiologic agents.
Main Results:
- Benzathine penicillin G remains the primary treatment for syphilis.
- Single-dose azithromycin and ceftriaxone are effective for chancroid; prolonged doxycycline or minocycline for lymphogranuloma venereum.
- Trimethoprim-sulfamethoxazole is preferred for donovanosis, and parenteral cephalosporins for disseminated gonococcemia; amoxicillin-clavulanic acid for genital bite wounds.
Conclusions:
- Effective management of bacterial STDs requires adherence to specific antibiotic regimens tailored to the causative agent.
- Monitoring evolving antimicrobial resistance is crucial for maintaining treatment efficacy.
- Updated therapeutic strategies are essential for controlling the global burden of STDs.
More Related Videos
10:29Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
11:17Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
Related Concept Videos
01:26Sexually Transmitted Infections
Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
01:30Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
A healthcare provider can diagnose a urinary tract infection (UTI) through several methods:Medical History and Symptoms: The provider will take a detailed medical history and ask about symptoms such as frequent urination, burning sensation during urination, and lower abdominal pain.Urinalysis: A clean-catch urine sample is collected in a sterile container and tested for the presence of bacteria, white blood cells (leukocytes), nitrites, blood, and protein. The presence of leukocytes and...
01:28Amebiasis
Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...
00:57Antibiotic Selection
Overview
01:18Trichomoniasis
Trichomonas vaginalis is a flagellated protozoan parasite and the causative agent of trichomoniasis, one of the most prevalent non-viral sexually transmitted infections in the United States. This extracellular parasite primarily colonizes the lower genitourinary tract in women—particularly the vagina—and in men, the urethra and prostate. Its structural and functional adaptations enable its survival, motility, and pathogenicity within the host environment.Structural Features and Host EntryT.
01:21Microbiota Modulation by Antibiotics
Antibiotics have revolutionized modern medicine by saving countless lives from bacterial infections. However, their widespread use has inadvertently harmed the delicate balance of the human gut microbiota. The gut microbiota, a complex community of bacteria, archaea, viruses, and fungi, plays a vital role in regulating metabolism, immune responses, and maintaining intestinal health. Antibiotics, especially broad-spectrum types, disrupt this ecosystem by eradicating both harmful and beneficial...